secwatch.observer — SEC 8-K summary
======================================

Issuer:     QuidelOrtho Corp (QDEL)
CIK:        0001906324
Form:       8-K
Filed at:   2024-02-16T23:59:59+00:00
Accession:  0001906324-24-000006
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

QuidelOrtho widens FY2024 adjusted diluted EPS range to $1.88-$3.60; midpoint unchanged
--------------------------------------------------------------------------------

- Corrected FY2024 adj. diluted EPS guidance: $1.88-$3.60 (midpoint $2.74 unchanged); previously narrower range.
- Total revenue guidance unchanged at $2.76-$3.07B; non-respiratory $2.30-$2.34B; respiratory $460-$730M.
- Adjusted EBITDA guidance unchanged at $565-$720M (21-24% margin).
- Correction filed Feb 16 after initial Feb 13 earnings release and guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1906324/000190632424000006/0001906324-24-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1906324/000190632424000006/qdel-20240216.htm
  HTML page:      https://secwatch.observer/filing/0001906324-24-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer